Skip to main content
. 2021 Jul 1;100(10):101371. doi: 10.1016/j.psj.2021.101371

Figure 2.

Figure 2

Expression of LPS in liver and duodenum. Note: C: Control group; EC: E. coli infection group; L: Schisandrin A low dose group; M: Schisandrin A medium dose group; H: Schisandrin A high dose group; F: positive drug group. * Significant difference with control group (P < 0.05). # Significant difference with E. coli infection group (P < 0.05).